Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers
NCT00110591
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
PRO 140
Sponsor
CytoDyn, Inc.